(PRWEB) April 05, 2014
The "Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] - Global Forecasts To 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Browse 220 market data tables with 33 figures spread through 504 pages and in-depth TOC on Biomaterials Market"
Early buyers will receive 10% customization on this report.
This report studies the global biomaterial market over the forecast period of 2012-2017. The global market for biomaterials is estimated at $44.0 billion in 2012 and is poised to grow at a CAGR of 15% from 2012 to 2017 to reach $88.4 billion by 2017.
Ask for Free PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=393
The global biomaterial market is broadly segmented into two categories, by type and by application. The global biomaterial market, by type, is broadly categorized into metals, ceramics, polymers, and natural biomaterials. The biomaterial applications market is broadly segmented into orthopedic, cardiovascular, neurological, dental, tissue engineering, wound healing, plastic surgery, ophthalmology and other applications such as gastrointestinal, urinary, bariatric surgery, and drug delivery system. In 2012, the cardiovascular biomaterial segment contributed 34.5% to the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to witness the highest growth in the coming years.
The biomaterial polymers market is expected to show the highest growth at a CAGR of 22.1% (2012-2017) due to tremendous ongoing research for the development of biodegradable and bio-compatible polymeric biomaterial and its use in a wide range of applications.
Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=393
With the emergence of biotechnology, the biomaterials have assumed a more important role in medical devices, tissue replacement, and surface coating applications. Developing from bio-inert materials (materials that do not react with biological environment) to biodegradable material, these biomaterials are widely used in the human body to improve the body functions and to replace the damage tissues of the body. Today, the biomaterial market stands at a size of $28.9 billion and has grown at a CAGR of more than 8% in the past two years. In spite of huge market size, the market is still in a growing phase; consider the fact that every year more than 100,000 heart valves, 200,000 pacemakers and 1 million orthopedic devices are implanted worldwide. This indicates the great opportunity in the market in terms of revenues and market growth. Improved patient benefits, increase in aging population, rising awareness, shorter product approval time, and large application area are proving out to be the major drivers for the biomaterial market. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market. Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth.
The report includes company profiles of major players such as DENTSPLY International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Depuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. The key raw material supplier companies are Carpenter Technology Corporation (U.S.), Materion Corporation (U.S.), Ulbrich Stainless Steel & Special Metals, Inc. (U.S.), Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), (Germany), Ceradyne, Inc. (U.S.), Kyocera Corporation (Japan), Bayer (Germany), Purac Biomaterials (Netherlands), DSM Biomedical, Inc. (U.S.), Evonik Industries (Germany), Cam Bioceramics (Netherlands), Ticona GmbH (Germany), and Landec Corporation (U.S.).
Browse Related Reports:
Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets